Deutsch English Français

Contact

EP0573605

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP0573605

EP0573605 - PREPARATION OF FACTOR IX [Right-click to bookmark this link]
Status	No opposition filed within time limit Status updated on 29.06.2001 Database last updated on 28.09.2024
Most recent event Tooltip	29.06.2001	No opposition filed within time limit	published on 16.08.2001 [2001/33]
Applicant(s)	For all designated states RHONE-POULENC RORER INTERNATIONAL (HOLDINGS) INC. 3711 Kennett Pike, Suite 200 Greenville, Delaware 19807 / US
	[2001/04]
Former [1995/52]	For all designated states RHONE-POULENC RORER INTERNATIONAL (HOLDINGS) INC. 5711 Kennett Pike, Suite 200 Greenville, Delaware 19807 / US
Former [1993/50]	For all designated states RHONE-POULENC RORER INTERNATIONAL (HOLDINGS) INC. Delaware Corporate Center I, 1 Righter Parkway, Suite 114 Wilmington, Delaware 19803 / US
Inventor(s)	01 / HUANG, Chin, C. 53 Briarcliff Lane Bourbonnais, IL 60914 / US
	02 / ENKOJI, Takashi 410 Seward Street Park Forest, IL 60466 / US
	03 / HO, Laura 5 Oxford Place Bourbonnais, IL 60914 / US
	04 / KLESZYNSKI, Richard, R. Rural Route 6, Box HE41 St. Anne, IL 60964 / US
	05 / WEEKS, Richard, L. Rural Route 1, Box 849 Kankakee, IL 60901 / US
	06 / FELDMAN, Fred 870 St. Andrews Way Frankfort, IL 60423 / US
	[1993/50]
Representative(s)	Lauppe, Hans Friedrich, et al Aventis Behring GmbH Postfach 12 30 35002 Marburg / DE
	[N/P]
Former [1996/19]	Lauppe, Hans Friedrich, Dr., et al Centeon Pharma GmbH, Postfach 12 30 35002 Marburg / DE
Former [1993/50]	Le Pennec, Magali, et al RHONE-POULENC RORER SA, Direction des Brevets, 20 Avenue Raymond Aron F-92165 Antony Cédex / FR
Application number, filing date	92908513.2	26.02.1992
	[1993/50]
	WO1992US01600
Priority number, date	US19910662927	01.03.1991 Original published format: US 662927
	[1993/50]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO9215324
	Date:	17.09.1992
	Language:	EN
	[1992/24]
	Type:	A1 Application with search report
	No.:	EP0573605
	Date:	15.12.1993
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 17.09.1992 takes the place of the publication of the European patent application.
	[1993/50]
	Type:	B1 Patent specification
	No.:	EP0573605
	Date:	30.08.2000
	Language:	EN
	[2000/35]
Search report(s)	International search report - published on:	US	17.09.1992
	(Supplementary) European search report - dispatched on:	EP	04.10.1994
Classification	IPC:	A61K38/36, C12N9/64	[2000/15]
	CPC:	C12N9/644 (EP,US); A61K38/4846 (EP,US); A61K47/02 (EP,US); A61K9/0019 (EP,US); A61P7/02 (EP); C07K16/40 (EP,US); (+) C12N9/96 (EP,US); C12Y304/21022 (EP,US) (-)
	Former IPC [1994/40]	A61K37/547, C12N9/64
	Former IPC [1993/50]	A61K37/547
Designated contracting states	AT, BE, CH, DE, DK, ES, FR, GB, GR, IT, LI, LU, MC, NL, SE [1993/50]
Title	German:	HERSTELLUNG VON FAKTOR-IX	[1993/50]
	English:	PREPARATION OF FACTOR IX	[1993/50]
	French:	PREPARATION DE FACTEUR IX	[1993/50]
Entry into regional phase	23.09.1993	National basic fee paid
	23.09.1993	Search fee paid
	23.09.1993	Designation fee(s) paid
	23.09.1993	Examination fee paid
Examination procedure	30.09.1992	Request for preliminary examination filed International Preliminary Examining Authority: DE
	23.09.1993	Examination requested [1993/50]
	14.09.1998	Despatch of a communication from the examining division (Time limit: M04)
	25.02.1999	Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
	07.05.1999	Reply to a communication from the examining division
	06.07.1999	Despatch of communication of intention to grant (Approval: No)
	17.01.2000	Despatch of communication of intention to grant (Approval: later approval)
	11.02.2000	Communication of intention to grant the patent
	22.05.2000	Fee for grant paid
	22.05.2000	Fee for publishing/printing paid
Opposition(s)	31.05.2001	No opposition filed within time limit [2001/33]
Request for further processing for:	07.05.1999	Request for further processing filed
	07.05.1999	Full payment received (date of receipt of payment) Request granted
	25.05.1999	Decision despatched
Fees paid	Renewal fee
	26.01.1994	Renewal fee patent year 03
	25.01.1995	Renewal fee patent year 04
	24.01.1996	Renewal fee patent year 05
	24.02.1997	Renewal fee patent year 06
	26.01.1998	Renewal fee patent year 07
	05.02.1999	Renewal fee patent year 08
	03.02.2000	Renewal fee patent year 09
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:	Search	[E]EP0496725 (IMMUNO AG [AT]) [E] 1-5,7-10,12,13,15,16,18,21,26-31* example 1 *
	International search	[X]US4379085 (WILLIAMS CRAIGENNE A, et al);
		[A]US4405603 (SCHWINN HORST [DE], et al);
		[A]US4411794 (SCHWINN HORST [DE], et al);
		[A]US4687664 (PHILAPITSCH ANTON [AT], et al);
		[A]US4725673 (HERRING STEVEN W [US]);
		[Y]US4770999 (KAUFMAN RANDAL J [US], et al);
		[XY]US4786726 (SMITH KENNETH J [US]);
		[A]US4981952 (YAN S BETTY [US]);
		[AP]US5055557 (ZIMMERMAN THEODORE S [US]);
		[AP]US5061789 (MOELLER WOLFGANG [DE], et al);
		[AP]US5071961 (KRAUS MICHAEL [DE], et al)
		[XY] - Vox Sanguinis, Volume 57, issued November 1989, T. BURNOUF et al., "Properties of a highly purified human plasma factor IX:c therapeutic concentrate prepared by conventional chromatography", pages 225-232, see page 226, "Materials and Methods" and "Purification", pages 227-228, Fig. 3 and Tables 1-2.
		[XY] - Proceedings of the National Academy of Sciences USA, Volume 82, issued June 1985, H.A. LIEBMAN et al., "Immunoaffinity purification of factor IX (Christmas factor) by using conformation-specific antibodies directed against the factor IX-metal complex", pages 3879-3883, see pages 3880 and 3882, Table 1 and Figs. 5-6.
		[A] - Vox Sanguinis, Volume 58, issued January 1990, J. THARAKAN et al., "Development of an immunoaffinity process for factor IX purification", pages 21-29, see entire document.
		[X] - Thrombosis Research, Volume 55, issued 01 July 1989, S.S. AHMAD et al., "Rapid purification of factor IX, factor X and prothrombin by immunoaffinity and ion exchange chromatography", pages 121-133, see pages 123-127, Figures 1-2, Table I.

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 34p